Geron reported $76.69M in Current Liabilities for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Amgen AMGN:US USD 15.69B 1.36B
Bio Techne TECH:US USD 128.39M 9.23M
Cti Biopharma CTIC:US USD 81.13M 51.36M
Cytokinetics CYTK:US USD 84.62M 8.12M
Esperion Therapeutics ESPR:US USD 92.31M 9.96M
Exelixis EXEL:US USD 324.36M 22.63M
Genmab GEN:DC DKK 1.82B 1.16B
Geron GERN:US USD 76.69M 6.11M
Gilead Sciences GILD:US USD 11.24B 814M
Macrogenics MGNX:US USD 48.61M 1.43M
Novartis NOVN:VX USD 28.66B 496M
Novavax NVAX:US USD 2.46B 791.98M
Pain Therapeutics PTIE:US USD 7.06M 1.24M
Seattle Genetics SGEN:US USD 818.4M 92.41M
YTE INCY:US USD 1.16B 150.48M